ASF Standards · Ambulatory Clinic · Standard 13
Standard 13 — Fertility & IVF
Criteria in this standard
13.1 — Embryology Lab Quality Control Is Verified, Not Assumed
13.2 — Hormone Stimulation Protocols Have Real, Documented Physician Oversight
13.3 — Multiple-Pregnancy Risk Is Explicitly Discussed Before Transfer
13.4 — High-Stakes Consent Reflects the Real Emotional and Financial Weight of the Decision
13.5 — A Witnessing Protocol Prevents Gamete and Embryo Mix-Up
13.2 — Hormone Stimulation Protocols Have Real, Documented Physician Oversight
13.3 — Multiple-Pregnancy Risk Is Explicitly Discussed Before Transfer
13.4 — High-Stakes Consent Reflects the Real Emotional and Financial Weight of the Decision
13.5 — A Witnessing Protocol Prevents Gamete and Embryo Mix-Up
13.1
Embryology Lab Quality Control Is Verified, Not Assumed
Non-Negotiable
Embryo and oocyte assessment follows a recognised international consensus standard, with laboratory conditions — temperature, air quality, incubator calibration — verified through defined, regular quality control, not assumed stable because equipment appears to be functioning.
In plain terms: The embryology laboratory follows an international consensus standard for assessing embryos, and its incubators, air quality, and temperatures are checked and recorded on a schedule.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | N/A | Full | Full | Full |
Why this matters
An embryo's survival depends on a stable environment: temperature within 0.2°C, CO2 within tight tolerance, pH constant, air free of volatile organic compounds. An incubator that drifts, an air handler that fails, or a workstation that cools kills embryos that would have become children. Laboratory quality control means continuous monitoring with alarms, daily recorded checks, calibrated instruments, and validated procedures for every step. Embryo assessment must follow a consensus standard (Istanbul, Vienna, or ESHRE) so grading is consistent and meaningful. A lab that cannot show its incubator logs cannot show its embryos were safe.
What good looks like
- Assessment consistently follows the recognised international standard.
- Laboratory conditions are verified through defined, regular quality control.
- A specific, followed response exists for any out-of-range reading.
Common failure modes
- Assessment practice varies by individual embryologist without a consistent standard.
- Laboratory conditions are assumed stable without regular verification.
- No defined response exists for an out-of-range reading.
Worked example
In practice
A fertility clinic with an embryology lab and two incubators.
BeforeIncubator temperatures were checked 'daily' by reading the display — which had never been calibrated against an external thermometer. CO2 was not independently verified. No VOC monitoring existed. Embryo grading was by the embryologist's judgment without reference to a published scheme. Success rates had declined over 18 months with no explanation.
ActionIndependent calibrated probes were installed in each incubator with continuous logging and alarms to a mobile phone. Daily checks of temperature, CO2, and pH are recorded on a log. Quarterly external calibration is contracted. VOC filtration was installed and air quality tested. The lab adopted the ESHRE Vienna consensus for embryo assessment with all embryologists trained. A monthly KPI review tracks fertilisation, cleavage, and blastocyst rates.
AfterThe Monitor reviewed six months of incubator logs, calibration certificates, air quality results, embryologist training records, and the KPI dashboard showing recovery of blastocyst rate. Verified.
If you are starting from zero — do this first
- Check your incubator temperature with an independent calibrated thermometer. Compare to the display.
- Find your incubator logs. If they are display readings only, that is the gap.
- Install continuous monitoring with alarms.
- Adopt a consensus embryo assessment standard and train to it.
The most common mistake: Trusting the incubator's own display — it can be wrong by a full degree without any alarm.
Self-assessment questions
1. Does embryo and oocyte assessment follow a recognised international consensus standard, applied consistently? — A named, recognised standard, applied by every embryologist consistently.
Evidence: Assessment protocol documentation
Evidence: Assessment protocol documentation
2. Are laboratory conditions — temperature, air quality, incubator calibration — verified through defined, regular quality control? — Regular, scheduled verification, not assumed from equipment appearing to function.
Evidence: Laboratory quality control log
Evidence: Laboratory quality control log
3. Is there a defined response if quality control identifies conditions outside acceptable range? — A specific action, not uncertainty about what happens when a reading is out of range.
Evidence: Out-of-range response protocol
Evidence: Out-of-range response protocol
Common reasons for a PARTIAL answer
- Temperature is monitored consistently but air quality checks are less regular. — Each laboratory condition can independently affect embryo development.
- Quality control happens but results aren't reviewed by someone with authority to act on them. — Monitoring without genuine review provides limited real protection.
- The assessment standard is followed for routine cases but applied less consistently for complex ones.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current assessment practice against the recognised international standard. |
| Week 2 | Establish or verify a defined, regular laboratory quality control schedule. |
| Week 3 | Define a specific response protocol for out-of-range conditions. |
| Ongoing | Review quality control logs and assessment consistency periodically. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Assessment standard review | Reviews assessment protocols against the recognised international consensus standard. |
| DOCUMENT | Quality control log review | Reviews laboratory condition quality control logs for consistency and regularity. |
| ASK | Out-of-range response interview | Asks laboratory staff what happens when a quality control reading is outside acceptable range. |
Supervisor tips
- Ask for actual quality control logs, not a general assurance conditions are stable. — Dated, specific records are the only real evidence of consistent verification.
- Ask two different embryologists to assess the same case criteria. — Consistent answers reveal genuine standardisation; differing answers reveal informal, individual practice.
Evidence base
[65] Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group of Embryology. The Istanbul consensus update: a revised ESHRE/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment. Hum Reprod. 2025 — establishes internationally recognised, evidence-based criteria for oocyte and embryo assessment.
Train your team: AMB-13 · Fertility & IVF on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.
13.2
Hormone Stimulation Protocols Have Real, Documented Physician Oversight
Non-Negotiable
Ovarian stimulation protocols are individually determined and monitored by a licensed physician based on this specific patient's response, following recognised clinical guidance — not a standardised protocol applied uniformly regardless of individual monitoring results.
In plain terms: A doctor personally sets and monitors each patient's stimulation protocol based on her response — with ultrasound and hormone results reviewed — not a standard protocol given to every patient.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | N/A | Full | Full | Full |
Why this matters
Ovarian stimulation done wrong causes ovarian hyperstimulation syndrome — a condition that can hospitalise, thrombose, and occasionally kill. Done cautiously in a poor responder, it produces no eggs and a wasted cycle. The dose must be individualised from the start (based on AMH, antral follicle count, age, BMI, and previous response) and adjusted during stimulation based on follicle growth and oestradiol levels. This requires a doctor reviewing every monitoring scan and blood result and making a documented decision. A clinic where nurses run 'the standard protocol' and the doctor sees the patient only at egg collection has no medical oversight of the most dangerous part of IVF.
What good looks like
- Protocols are genuinely individualised, reflected in real, patient-specific documentation.
- Protocols are adjusted based on this patient's own monitoring results.
- A specific, known OHSS recognition and management process exists.
Common failure modes
- A standardised protocol is applied uniformly regardless of individual patient profile.
- Protocols don't change despite individual monitoring results suggesting they should.
- No specific process exists for OHSS risk beyond general awareness.
Worked example
In practice
A fertility clinic running 300 cycles a year.
BeforePatients received one of three standard protocols based on age. Monitoring scans were done by nurses; results were noted but not reviewed by a doctor until egg collection. Three patients had been hospitalised with OHSS in the previous year. Dose adjustments were rare.
ActionA stimulation protocol policy was written: individualised starting dose from a documented assessment of AMH, AFC, age, BMI, and prior cycles; every monitoring scan and E2 result reviewed by the treating doctor the same day with a documented decision (continue, adjust, trigger, cancel); OHSS risk assessed at every visit with a defined trigger and freeze-all protocol for high-risk patients. Doctors sign every monitoring review.
AfterThe Monitor reviewed 20 cycle records: each had an individualised starting dose with rationale, same-day doctor review of every monitoring visit, and OHSS risk documented. Three cycles showed dose adjustments; one a freeze-all decision. OHSS hospitalisations: 0 in six months. Verified.
If you are starting from zero — do this first
- Pull ten cycle records: was the starting dose individualised with a written rationale?
- Check whether a doctor reviewed each monitoring scan the same day. Is it signed?
- Write an OHSS risk protocol with freeze-all criteria.
- Require doctor sign-off on every monitoring decision.
The most common mistake: Choosing the protocol by age band alone — a 32-year-old with an AMH of 40 and one with an AMH of 2 need completely different treatment.
Self-assessment questions
1. Is the stimulation protocol individually determined for this specific patient, not a standard protocol applied uniformly? — A real, individual clinical decision, reflecting this patient's own profile.
Evidence: Individual protocol determination record
Evidence: Individual protocol determination record
2. Is the protocol adjusted based on this patient's actual monitoring results during stimulation? — Genuine responsiveness to real-time monitoring data, not a fixed plan followed regardless.
Evidence: Protocol adjustment record
Evidence: Protocol adjustment record
3. Is there a defined process for recognising and managing ovarian hyperstimulation syndrome risk specifically? — A specific, known process for this specific serious risk, not general awareness alone.
Evidence: OHSS risk management protocol
Evidence: OHSS risk management protocol
Common reasons for a PARTIAL answer
- Initial protocol determination is individualised but adjustments during stimulation become more standardised. — Ongoing responsiveness to monitoring matters as much as the initial individualised decision.
- Monitoring happens but isn't consistently reviewed by the physician in time to adjust the protocol meaningfully. — Delayed review limits the ability to actually respond to what monitoring reveals.
- OHSS risk is recognised for high-risk patients but the process isn't consistently applied to lower apparent risk.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review a sample of stimulation protocols for genuine individual determination. |
| Week 2 | Establish a consistent process for adjusting protocols based on real-time monitoring. |
| Week 3 | Define and brief staff on a specific OHSS recognition and management process. |
| Ongoing | Audit protocol individualisation and OHSS management readiness periodically. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Individual protocol review | Reviews records for evidence of genuine, individual protocol determination. |
| DOCUMENT | Adjustment record review | Reviews whether protocols are adjusted based on individual monitoring results during stimulation. |
| ASK | OHSS management interview | Asks the physician to describe the specific process for recognising and managing OHSS risk. |
Supervisor tips
- Compare two different patients' protocols and documented reasoning. — Genuinely different content reveals real individualisation; near-identical protocols reveal standardisation.
- Ask the physician to describe a specific OHSS case, real or hypothetical, in detail. — Specific, detailed knowledge reveals genuine readiness rather than general awareness.
Evidence base
[66] European Society of Human Reproduction and Embryology. ESHRE guideline: ovarian stimulation for IVF/ICSI — an update. Hum Reprod. 2025 — establishes individualised, response-based protocol adjustment as core to safe ovarian stimulation practice.
Train your team: AMB-13 · Fertility & IVF on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.
13.3
Multiple-Pregnancy Risk Is Explicitly Discussed Before Transfer
Core
Before every embryo transfer, the patient has a genuine, documented conversation about multiple-pregnancy risk specific to the number of embryos being considered, including the option of single embryo transfer — not a generic consent form covering "embryo transfer" without this specific discussion.
In plain terms: Before every embryo transfer, the doctor talks with the patient about the risk of twins or triplets for the number of embryos proposed, and offers single embryo transfer — and this is documented.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | N/A | Full | Full | Full |
Why this matters
Twin pregnancy is the most common serious complication of IVF: preterm birth, low birthweight, cerebral palsy, maternal haemorrhage, and neonatal death are all several times more likely than in singleton pregnancy. Transferring two embryos to increase the chance of pregnancy trades a small gain in pregnancy rate for a large increase in harm. International guidance recommends single embryo transfer for most patients. The patient must understand this and decide — and the decision must be documented. A clinic that routinely transfers two 'because patients want the best chance' has not had this conversation.
What good looks like
- Every patient has a specific, documented multiple-pregnancy risk conversation.
- Single embryo transfer is genuinely presented as a real option.
- Patients can explain back the risk relevant to their own decision.
Common failure modes
- Multiple-pregnancy risk is folded into general consent without specific discussion.
- Multiple-embryo transfer is presented as the default with no genuine alternative offered.
- Patients cannot describe the specific risk relevant to their transfer.
Worked example
In practice
A fertility clinic with a 35% twin rate — more than double the national target.
BeforeDouble embryo transfer was the default. Multiple pregnancy risk was mentioned in a leaflet. The Coordinator interviewed ten patients post-transfer: seven did not know twins were a serious risk; four had not been offered single embryo transfer. Twin pregnancies had produced two preterm births with NICU admission in the previous year.
ActionA pre-transfer consultation was made mandatory: the doctor discusses this patient's likely pregnancy rate with one embryo versus two, the specific multiple pregnancy risks, and recommends single embryo transfer where prognosis is good. The conversation is documented with the patient's decision and reasoning. A clinic policy set single embryo transfer as default for patients under 38 with a good-quality blastocyst.
AfterThe Monitor reviewed 25 transfer records: all had documented multiple pregnancy discussions and patient decisions. Single embryo transfer rate up from 30% to 78%; twin rate down to 9%. Verified.
If you are starting from zero — do this first
- Calculate your twin rate. Above 15% signals a problem.
- Interview five post-transfer patients: do they know twins are a serious risk?
- Make single embryo transfer the default for good-prognosis patients.
- Document the conversation and the patient's decision every time.
The most common mistake: Treating twin pregnancy as a bonus rather than a complication — patients often do, and the clinic must correct that.
Self-assessment questions
1. Does every patient have a specific, documented conversation about multiple-pregnancy risk before transfer? — A specific conversation about this risk, not folded into general transfer consent.
Evidence: Multiple-pregnancy risk discussion documentation
Evidence: Multiple-pregnancy risk discussion documentation
2. Is single embryo transfer genuinely presented as an option, not just multiple-embryo transfer as the default? — A genuine choice presented, not a default the patient would need to actively push back against.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
3. Can the patient explain back the specific risk relevant to their own transfer decision? — Tests genuine understanding, not just that a conversation occurred.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
Common reasons for a PARTIAL answer
- The discussion happens for patients considering multiple-embryo transfer but not those already planning single transfer. — Even a patient inclined toward single transfer benefits from understanding why the choice matters.
- Risk is mentioned but single embryo transfer isn't genuinely presented as an equally valid option. — A mentioned risk without a genuine alternative doesn't provide a real choice.
- The conversation happens once, early in treatment, and isn't revisited at the actual point of transfer decision.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current pre-transfer consent practice for specific multiple-pregnancy risk discussion. |
| Week 2 | Build a specific discussion point into the pre-transfer consultation, distinct from general consent. |
| Week 3 | Train staff to genuinely present single embryo transfer as a real option. |
| Ongoing | Spot-check patient understanding after pre-transfer consultations. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Risk discussion documentation review | Reviews records for a specific, documented multiple-pregnancy risk discussion distinct from general consent. |
| OBSERVE | Transfer consultation observation | Observes an actual pre-transfer consultation for genuine discussion of single embryo transfer as an option. |
| ASK | Patient understanding check | Asks a patient to explain back the specific risk relevant to their own transfer decision. |
Supervisor tips
- Ask the patient, not the clinician, to describe the risk discussion they had. — This tests actual understanding, not staff confidence in their own explanation.
- Ask specifically whether single embryo transfer was presented as a genuine option. — A direct question often reveals what a general consent review won't.
Evidence base
[67] Single embryo transfer, with explicit discussion of multiple-pregnancy risk as part of the transfer decision, is established international guidance for reducing avoidable multiple-pregnancy risk in IVF, distinct from general transfer procedure consent.
Train your team: AMB-13 · Fertility & IVF on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.
13.4
High-Stakes Consent Reflects the Real Emotional and Financial Weight of the Decision
Core
Consent conversations for fertility treatment genuinely address the real emotional and financial weight of the decision — realistic success rates specific to this patient, not generic clinic statistics, and the real possibility of an unsuccessful cycle — not a form focused only on the physical procedure.
In plain terms: Consent for IVF honestly covers this patient's real chance of success, the emotional and financial cost, and what happens if it does not work — not generic clinic statistics and a signature.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | N/A | Full | Full | Full |
Why this matters
A 42-year-old with low ovarian reserve has a live birth rate per cycle of perhaps 5%. If she is shown the clinic's overall figure of 35%, she has been misled. Fertility treatment is one of the most emotionally and financially loaded decisions in medicine: patients spend savings, take loans, and endure repeated loss. Honest consent means age- and diagnosis-specific success rates from the clinic's own data, the cumulative cost of a realistic number of cycles, the emotional impact, the alternatives including stopping, and time to decide. A consent process designed to close the sale is not consent.
What good looks like
- Success rates discussed are specific to this patient, not generic clinic statistics.
- The real possibility of an unsuccessful cycle is genuinely, honestly discussed.
- Financial commitment, including possible multiple cycles, is discussed upfront.
Common failure modes
- Success rates cited are generic clinic marketing figures, not individualised.
- Consent implicitly assumes success, without genuine discussion of failure possibility.
- Financial discussion happens only as costs are being incurred, not upfront.
Worked example
In practice
A fertility clinic that quoted its overall live birth rate on its website and in consultations.
BeforePatients were told the clinic's live birth rate (36% per cycle). Age-specific rates were not discussed. Financial counselling covered the cost of one cycle only. A 43-year-old had spent her savings on four cycles with a realistic success rate under 4% per cycle; nobody had told her that figure.
ActionConsent was restructured: the doctor presents this patient's success rate by age and diagnosis from the clinic's own outcomes data; a financial counsellor presents the cost of one, two, and three cycles; the emotional impact and counselling access are discussed; the option of not proceeding is explicitly offered; a 48-hour cooling-off period is required before treatment begins; the patient signs a consent that records the specific success rate she was told.
AfterThe Monitor reviewed 20 consents: each recorded a patient-specific success rate, multi-cycle cost, and the cooling-off period. Interviewed two patients who could state their own success rate. Verified.
If you are starting from zero — do this first
- Ask five patients what success rate they were told. Compare to their age-specific rate.
- Calculate your own success rates by age band and diagnosis.
- Present those — not the overall figure — in every consultation.
- Add a cooling-off period and record the rate given on the consent.
The most common mistake: Quoting the clinic's overall success rate to a patient whose personal rate is a fraction of it.
Self-assessment questions
1. Does consent include realistic success rates specific to this patient's own profile, not generic clinic-wide statistics? — Individualised, honest expectations, not marketing-oriented general figures.
Evidence: Individualised success rate discussion documentation
Evidence: Individualised success rate discussion documentation
2. Is the real possibility of an unsuccessful cycle genuinely discussed, not treated as an unlikely exception? — Honest acknowledgement, not an implicit assumption of success.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
3. Does the conversation address the real financial commitment, including the possibility of multiple cycles? — Genuine financial transparency, not deferred until costs are already being incurred.
Evidence: Financial discussion documentation
Evidence: Financial discussion documentation
Common reasons for a PARTIAL answer
- Individualised success rates are discussed for the first cycle but not revisited for subsequent attempts. — Each cycle's own realistic likelihood deserves its own honest discussion.
- Financial discussion covers the immediate cycle cost but not the realistic possibility of needing further cycles. — Genuine financial transparency includes the realistic full picture, not only the immediate cost.
- The conversation is thorough at initial consultation but not revisited as treatment progresses.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current consent practice for individualised, not generic, success rate discussion. |
| Week 2 | Build individualised success rate and unsuccessful-cycle discussion into the consent process. |
| Week 3 | Establish upfront financial discussion covering realistic multiple-cycle possibility. |
| Ongoing | Spot-check patient understanding of both clinical and financial realities. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Individualised success rate review | Reviews consent documentation for patient-specific, not generic, success rate discussion. |
| OBSERVE | Consent conversation observation | Observes an actual consent conversation for genuine discussion of unsuccessful-cycle possibility. |
| ASK | Financial discussion interview | Asks a patient whether the real financial commitment, including possible multiple cycles, was discussed upfront. |
Supervisor tips
- Ask a patient what success rate they were told, and compare it to this patient's actual individual profile. — This reveals whether figures given were genuinely individualised or generic.
- Ask whether the possibility of needing more than one cycle was discussed before treatment began. — This is where financial transparency most commonly falls short in practice.
Evidence base
[68] Realistic, individualised success rate discussion, distinct from generic clinic-wide statistics, is identified as an essential component of genuinely informed consent in fertility treatment, given the significant emotional and financial stakes involved.
Train your team: AMB-13 · Fertility & IVF on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.
13.5
A Witnessing Protocol Prevents Gamete and Embryo Mix-Up
Non-Negotiable
Every critical step involving gamete or embryo handling — collection, insemination, cryopreservation, thaw, transfer — is verified through a defined witnessing protocol, either double manual witnessing by a second qualified person or a certified electronic witnessing system, with every step traceable.
In plain terms: Every time eggs, sperm, or embryos are handled — collected, fertilised, frozen, thawed, transferred — two people or an electronic system confirm they belong to the right patient.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | N/A | Full | Full | Full |
Why this matters
An embryo mix-up is the catastrophe fertility clinics exist to prevent: a child born to the wrong parents, a genetic child lost, a family destroyed, a clinic closed. It happens through a moment's inattention in a lab handling dozens of samples with similar labels. The defence is witnessing: at every critical step, a second trained person (or an RFID/barcode electronic witnessing system) independently confirms the identity of the patient, the sample, and the destination — and records it. No step is skipped because the lab is busy. No witness is the person who did the step.
What good looks like
- Every critical step is covered by a defined witnessing protocol.
- Witnessing is genuinely independent, whether manual or certified electronic.
- Every witnessed step is traceable through a retained, specific record.
Common failure modes
- Some critical steps lack a defined witnessing protocol.
- Witnessing is not genuinely independent, or is skipped under time pressure.
- No retained record exists confirming witnessing actually occurred for a given step.
Worked example
In practice
A fertility clinic laboratory handling 20 patients' samples on a busy day.
BeforeWitnessing was done 'when possible.' On busy days, embryologists worked alone and signed the witness line themselves. Labels were handwritten. A near-miss occurred when two patients with the same surname had samples on adjacent workstations.
ActionA witnessing protocol was written listing every critical step: oocyte collection labelling, sperm preparation, insemination/ICSI, embryo culture dish labelling, cryopreservation, thaw, and transfer. Each requires a second person to independently verify patient ID (two identifiers), sample ID, and destination, and sign. The witness cannot be the operator. Staffing was adjusted so a witness is always available. An electronic witnessing system was budgeted for the following year.
AfterThe Monitor observed an ICSI procedure and a transfer with double witnessing performed and recorded. Reviewed 30 witness records with no self-witnessing. Verified.
If you are starting from zero — do this first
- Pull 20 witness records. Is any witness the same person as the operator?
- List every critical step and require a witness for each.
- Adjust staffing so a witness is always available.
- Budget for electronic witnessing.
The most common mistake: Allowing the embryologist to sign as witness for their own work on busy days — the busy day is when the mistake happens.
Self-assessment questions
1. Is every critical step — collection, insemination, cryopreservation, thaw, transfer — covered by a defined witnessing protocol? — Every critical step specifically, not a general awareness of the importance of care.
Evidence: Witnessing protocol coverage documentation
Evidence: Witnessing protocol coverage documentation
2. Is witnessing genuinely independent — a second qualified person or certified electronic system — not the same person self-confirming? — Genuine independence, whether human or verified electronic system.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
3. Is every witnessed step traceable after the fact, with a retained record of who witnessed what and when? — A real, retained record, not an assumption that witnessing happened because the protocol exists.
Evidence: Witnessing traceability record
Evidence: Witnessing traceability record
Common reasons for a PARTIAL answer
- Witnessing is rigorous for embryo transfer but less consistently applied to earlier steps like insemination. — Every critical step carries the same real mix-up risk, not transfer alone.
- An electronic witnessing system exists but isn't used consistently for every applicable step. — A system that exists but isn't consistently used doesn't provide the intended protection.
- Witnessing happens but records don't specify exactly which steps were witnessed by whom.
Implementation plan
| When | What |
|---|---|
| Week 1 | Map every critical gamete and embryo handling step against current witnessing coverage. |
| Week 2 | Close any gap in witnessing coverage for critical steps. |
| Week 3 | Establish specific, retained traceability records for every witnessed step. |
| Ongoing | Audit witnessing consistency and traceability records periodically. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Protocol coverage review | Reviews the witnessing protocol for coverage of every critical handling step. |
| OBSERVE | Witnessing independence observation | Observes an actual witnessed step for genuine independence between the operator and witness. |
| DOCUMENT | Traceability record review | Reviews records for retained, specific traceability of witnessed steps. |
Supervisor tips
- Ask to see the traceability record for a specific, recent case. — A specific, real record is the only genuine evidence witnessing actually happened as described.
- Observe a witnessed step directly if timing allows. — Genuine independence between operator and witness is best confirmed through direct observation.
Evidence base
[69] Human Fertilisation and Embryology Authority. Code of Practice. 9th ed. London: HFEA; 2021 — mandates witnessing, either double manual witnessing by a second qualified individual or a certified electronic witnessing system, at every critical step of gamete and embryo handling.
Train your team: AMB-13 · Fertility & IVF on GMJ Academy →
This course teaches practical implementation of this standard. Free to enroll. ASF certificate on completion.